+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Nitro Compounds 5521-38-0
5521-38-0,MFCD00511837
Catalog No.:AA00I9RO

5521-38-0 | 2-(4-(4-nitrophenyl)piperazin-1-yl)ethanol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$90.00   $63.00
- +
1g
95%
in stock  
$103.00   $73.00
- +
5g
95%
in stock  
$344.00   $241.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00I9RO
Chemical Name:
2-(4-(4-nitrophenyl)piperazin-1-yl)ethanol
CAS Number:
5521-38-0
Molecular Formula:
C12H17N3O3
Molecular Weight:
251.2817
MDL Number:
MFCD00511837
SMILES:
OCCN1CCN(CC1)c1ccc(cc1)[N+](=O)[O-]
Properties
Properties
 
Form:
Solid  
MP:
97-99℃  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
266  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
3  
XLogP3:
1  

Upstream Synthesis Route

[1]Patent:WO2015/92431,2015,A1,.Locationinpatent:Page/Pagecolumn236

[2]Patent:WO2015/27222,2015,A2,.Locationinpatent:Paragraph0322

[3]Patent:WO2012/59932,2012,A1,.Locationinpatent:Page/Pagecolumn112-113

[4]Patent:WO2016/138527,2016,A1,.Locationinpatent:Paragraph00212

[5]JournalofMedicinalChemistry,2005,vol.48,#7,p.2371-2387

[6]Patent:US2003/13708,2003,A1,

[7]Patent:US2004/87575,2004,A1,

[8]Patent:US2004/110745,2004,A1,

[1]EuropeanJournalofMedicinalChemistry,2017,vol.132,p.204-218

[2]JournaloftheBrazilianChemicalSociety,2010,vol.21,#1,p.63-70

[3]Patent:WO2005/9978,2005,A1,.Locationinpatent:Page59

[4]Patent:WO2005/42518,2005,A2,.Locationinpatent:Page/Pagecolumn59

[1]Patent:WO2015/27222,2015,A2,.Locationinpatent:Paragraph0323

[2]Patent:WO2012/59932,2012,A1,.Locationinpatent:Page/Pagecolumn113

[3]JournalofMedicinalChemistry,2005,vol.48,#7,p.2371-2387

[4]Patent:US2004/87575,2004,A1,

[5]Patent:US2003/13708,2003,A1,

[6]Patent:US2004/110745,2004,A1,

[7]Patent:WO2015/92431,2015,A1,.Locationinpatent:Page/Pagecolumn237

[8]Patent:WO2016/138527,2016,A1,.Locationinpatent:Paragraph00214

[9]EuropeanJournalofMedicinalChemistry,2019,p.690-709

Downstream Synthesis Route

[1]Patent:WO2015/92431,2015,A1.Locationinpatent:Page/Pagecolumn236

[2]Patent:WO2015/27222,2015,A2.Locationinpatent:Paragraph0322

[3]Patent:WO2012/59932,2012,A1.Locationinpatent:Page/Pagecolumn112-113

[4]Patent:WO2016/138527,2016,A1.Locationinpatent:Paragraph00212

[5]Patent:US2019/106436,2019,A1.Locationinpatent:Paragraph0622-0624

[6]JournalofMedicinalChemistry,2005,vol.48,p.2371-2387

[7]Patent:US2003/13708,2003,A1

[8]Patent:US2004/87575,2004,A1

[9]Patent:US2004/110745,2004,A1

[10]EuropeanJournalofMedicinalChemistry,2019,vol.163,p.690-709

[1]Patent:WO2015/27222,2015,A2.Locationinpatent:Paragraph0323

[2]Patent:US2019/106436,2019,A1.Locationinpatent:Paragraph0622;0625-0626

[3]Patent:WO2012/59932,2012,A1.Locationinpatent:Page/Pagecolumn113

[4]JournalofMedicinalChemistry,2005,vol.48,p.2371-2387

[5]Patent:US2004/87575,2004,A1

[6]Patent:US2003/13708,2003,A1

[7]Patent:WO2015/92431,2015,A1.Locationinpatent:Page/Pagecolumn237

[8]Patent:WO2016/138527,2016,A1.Locationinpatent:Paragraph00214

[9]EuropeanJournalofMedicinalChemistry,2019,vol.163,p.690-709

5521-38-0   
8-cyclopentyl-2-{4-4-(2-hydroxy-ethyl)-piperazin-1-yl-phenylamino}-5-methyl-8<i>H</i>-pyrido2,3-<i>d</i>pyrimidin-7-one 

[1]JournalofMedicinalChemistry,2005,vol.48,p.2371-2387

[1]EuropeanJournalofMedicinalChemistry,2017,vol.132,p.204-218

[2]JournaloftheBrazilianChemicalSociety,2010,vol.21,p.63-70

[3]Patent:WO2005/9978,2005,A1.Locationinpatent:Page59

[4]Patent:WO2005/42518,2005,A2.Locationinpatent:Page/Pagecolumn59

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 5521-38-0
115619-00-6

115619-00-6

 16155-03-6

16155-03-6

 1030627-12-3

1030627-12-3

 260252-87-7

260252-87-7

 5521-39-1

5521-39-1

 6269-89-2

6269-89-2
Building Blocks
More >
Tags:5521-38-0 Molecular Formula|5521-38-0 MDL|5521-38-0 SMILES|5521-38-0 2-(4-(4-nitrophenyl)piperazin-1-yl)ethanol